A large analysis of weight-loss drugs like Ozempic and Wegovy has surprised health researchers, who found links to multiple new benefits – and some new side effects.
Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...
Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to treat ...
The first study to assess how weight-loss drugs affect the whole of human health has discovered an "eye-opening" impact on ...
Weight loss jabs such as Wegovy may reduce risk of dementia by easing inflammation in the brain, scientists say. The drugs ...
Analysis of drugs such as Ozempic finds a lower health risk for 42 conditions but a higher rate of disorders such as arthritis ...
My husband died aged 72 from prostate cancer. He used talcum powder daily for 50 years and I read recently that it was linked ...
Researchers from the Washington University School of Medicine looked at the health outcomes among more than two million people taking the popular weight-loss medications.
Over 2 million people were included in new research to test these drugs against 175 different health outcomes.
The findings, based on an analysis of records from 2.5 million VA patients, support much of what scientists already suspected ...
An observational study has uncovered a possible link between taking GLP-1s and increased risk of kidney, pancreas and gut ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback